Progression of late-stage adenoma is marked by dysregulated DNMT methylation and demethylation, shifting macrophages toward an M2 phenotype that enhances production of vascular endothelial growth factor (VEGF) and TGF-β, supporting tumor survival and metastasis 81. The gene discussed is VEGFA; the disease is adenoma.